XOMA Royalty (XOMA) Current Leases (2019 - 2026)
XOMA Royalty's (XOMA) quarterly Current Leases came in at $2.4 million in Q1 2026, up 421.13% year-on-year from $459000.0 in Q1 2025, and down 2.92% quarter-over-quarter from $2.5 million in Q4 2025.
XOMA Royalty (XOMA) Current Leases (2019 - 2026) Analysis & Trends
XOMA Royalty has disclosed Current Leases across 8 years of filings, most recently posting $2.4 million for Q1 2026.
- Current Leases for Q1 2026 came in at $2.4 million, up 421.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (up 421.13% YoY), and the FY2025 annual result was $2.5 million, up 516.0% from the prior year.
- Current Leases came in at $2.4 million for Q1 2026 at XOMA Royalty, down from $2.5 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $2.5 million in Q3 2025 to a low of $17000.0 in Q2 2023.
- The 5-year median for Current Leases is $291000.0 (2022), against an average of $637187.5.
- Across the five-year window, Current Leases sank 87.22% in 2023 and soared 2252.94% in 2024, its largest moves.
- XOMA Royalty's Current Leases stood at $34000.0 in 2022, then surged by 58.82% to $54000.0 in 2023, then soared by 640.74% to $400000.0 in 2024, then soared by 516.0% to $2.5 million in 2025, then decreased by 2.92% to $2.4 million in 2026.
- The last three Current Leases figures came in at $2.4 million (Q1 2026), $2.5 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 42,980.09 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - | 2.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.39 Mn |
| Dec 31, 2025 | 2.46 Mn |
| Sep 30, 2025 | 2.50 Mn |
| Jun 30, 2025 | 472,000.00 |
| Mar 31, 2025 | 459,000.00 |
| Dec 31, 2024 | 400,000.00 |
| Sep 30, 2024 | 434,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 54,000.00 |
| Jun 30, 2023 | 17,000.00 |
| Mar 31, 2023 | 69,000.00 |
| Dec 31, 2022 | 34,000.00 |
| Sep 30, 2022 | 85,000.00 |
| Jun 30, 2022 | 133,000.00 |
| Mar 31, 2022 | 182,000.00 |
| Dec 31, 2021 | 195,000.00 |
| Sep 30, 2021 | 191,000.00 |
| Jun 30, 2021 | 187,000.00 |
| Mar 31, 2021 | 183,000.00 |